{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:47:32Z","timestamp":1793490452541,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation (NRF)","doi-asserted-by":"crossref","award":["98345"],"award-info":[{"award-number":["98345"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijantimicag.2017.06.010","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T10:00:50Z","timestamp":1498644050000},"page":"311-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["The chemotherapeutic potential of chalcones against leishmaniases: a review"],"prefix":"10.1016","volume":"51","author":[{"given":"Nasir","family":"Tajuddeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtala Bindawa","family":"Isah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukhtar Adeiza","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanie R.","family":"van Heerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Auwal","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.theochem.2009.09.050","article-title":"Molecular modeling as a promising tool to study dendrimer prodrugs delivery","volume":"939","author":"Giarolla","year":"2010","journal-title":"J Mol Struct Theochem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.parint.2009.12.009","article-title":"Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens","volume":"59","author":"Vendrametto","year":"2010","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0025","series-title":"Neglected tropical diseases\u2014sub-Saharan Africa","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-319-25471-5_5","article-title":"Leishmaniasis","author":"Hailu","year":"2016"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0030","first-page":"287","article-title":"Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014","volume":"91","author":"WHO","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/S0365-05962011000300012","article-title":"Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review","volume":"86","author":"Almeida","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0040","doi-asserted-by":"crossref","first-page":"32376","DOI":"10.1039\/C5RA02669E","article-title":"Antileishmanial drug discovery: comprehensive review of the last 10 years","volume":"5","author":"Sangshetti","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijantimicag.2017.01.033","article-title":"Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system","volume":"50","author":"Monteiro","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpddr.2012.01.003","article-title":"Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?","volume":"2","author":"Freitas-Junior","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0055","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1016\/j.ijid.2009.06.010","article-title":"Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure\u2014a case report and brief review of the literature","volume":"14","author":"Rybniker","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0060","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.21873\/anticanres.11421","article-title":"Quantitative structure\u2013cytotoxicity relationship of chalcones","volume":"37","author":"Sakagami","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2016.02.013","article-title":"A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia","volume":"774","author":"Luo","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0075","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/acs.jnatprod.5b00155","article-title":"Antibacterial balsacones J\u2013M, hydroxycinnamoylated dihydrochalcones from Populus balsamifera buds","volume":"78","author":"Simard","year":"2015","journal-title":"J Nat Prod"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/14786419.2013.869694","article-title":"Anti-influenza A virus activity of a new dihydrochalcone diglycoside isolated from the Egyptian seagrass Thalassodendron ciliatum (Forsk.) den Hartog","volume":"28","author":"Mohammed","year":"2014","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2015.02.040","article-title":"An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo [3,4-b][1,4] diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents","volume":"93","author":"Insuasty","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jep.2017.01.028","article-title":"Antioxidative and anticancer properties of Licochalcone A from licorice","volume":"198","author":"Chen","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","article-title":"A review of anti-infective and anti-inflammatory chalcones","volume":"42","author":"Nowakowska","year":"2007","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0100","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/0929867306666220401182509","article-title":"Bioactivities of chalcones","volume":"6","author":"Elias","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/092986712803414132","article-title":"Exploring pharmacological significance of chalcone scaffold: a review","volume":"19","author":"Sahu","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejmech.2014.08.033","article-title":"Recent developments in biological activities of chalcones: a mini review","volume":"85","author":"Singh","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0115","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1017\/S0031182016000718","article-title":"A systematic review of pentacyclic triterpenes and their derivatives as chemotherapeutic agents against tropical parasitic diseases","volume":"143","author":"Isah","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0120","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/AAC.37.12.2550","article-title":"Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania","volume":"37","author":"Chen","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/43.6.793","article-title":"The antileishmanial activity of novel oxygenated chalcones and their mechanism of action","volume":"43","author":"Zhai","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0130","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/AAC.43.5.1234","article-title":"Selective effect of 2\u2032,6\u2032-dihydroxy-4\u2032-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis","volume":"43","author":"Torres-Santos","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fitote.2014.05.009","article-title":"Antileishmanial activity evaluation of adunchalcone, a new prenylated dihydrochalcone from Piper aduncum L","volume":"97","author":"Dal Picolo","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0140","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/S0968-0896(03)00406-1","article-title":"Antileishmanial activities of dihydrochalcones from Piper elongatum and synthetic related compounds. Structural requirements for activity","volume":"11","author":"Hermoso","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0145","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1055\/s-0031-1298459","article-title":"Dihydrochalcones and benzoic acid derivatives from Piper dennisii","volume":"78","author":"Cabanillas","year":"2012","journal-title":"Planta Med"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.phytol.2011.08.001","article-title":"Activity-guided isolation of antileishmanial compounds from Piper hispidum","volume":"4","author":"Ruiz","year":"2011","journal-title":"Phytochem Lett"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/np049682k","article-title":"Antiprotozoal compounds from Psorothamnus polydenius","volume":"68","author":"Salem","year":"2005","journal-title":"J Nat Prod"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/np0502600","article-title":"Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities","volume":"69","author":"Salem","year":"2006","journal-title":"J Nat Prod"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.phymed.2006.11.027","article-title":"Cytotoxic and antiprotozoal activity of flavonoids from Lonchocarpus spp","volume":"14","author":"Borges-Argaez","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14786419.2015.1030740","article-title":"Evaluation of leishmanicidal and trypanocidal activities of phenolic compounds from Calea uniflora Less","volume":"30","author":"Lima","year":"2016","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ptr.701","article-title":"In vitro leishmanicidal activity of naturally occurring chalcones","volume":"15","author":"Kayser","year":"2001","journal-title":"Phytother Res"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0180","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.bmcl.2015.06.085","article-title":"The 2\u2032,4\u2032-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species","volume":"25","author":"Passalacqua","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ejmech.2008.04.016","article-title":"Synthesis, biological evaluation and SAR of sulfonamide 4-methoxychalcone derivatives with potential antileishmanial activity","volume":"44","author":"Andrighetti-Fr\u00f6hner","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0190","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/S0968-0896(03)00233-5","article-title":"Structure\u2013activity relationships of antileishmanial and antimalarial chalcones","volume":"11","author":"Liu","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0195","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1016\/j.bmc.2011.06.023","article-title":"Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure\u2013activity relationship (SAR)","volume":"19","author":"Bello","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exppara.2013.11.003","article-title":"Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis","volume":"136","author":"de Mello","year":"2014","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejmech.2014.05.034","article-title":"Synthesis and biological evaluation of chalcones as potential antileishmanial agents","volume":"81","author":"Gupta","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0210","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/jm401893j","article-title":"Synthesis, structure\u2013activity relationships, and biological studies of chromenochalcones as potential antileishmanial agents","volume":"57","author":"Shivahare","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0215","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.bmcl.2015.05.072","article-title":"Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds","volume":"25","author":"Passalacqua","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrid molecules: the privileged scaffolds for various pharmaceuticals","volume":"124","author":"Mishra","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0225","doi-asserted-by":"crossref","first-page":"13251","DOI":"10.3390\/molecules190913251","article-title":"Synthesis, leishmanicidal and cytotoxic activity of triclosan-chalcone, triclosan-chromone and triclosan-coumarin hybrids","volume":"19","author":"Otero","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0230","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jm7012166","article-title":"2-(3-aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones: a new antileishmanial chemotype","volume":"51","author":"Reichwald","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0235","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2016.03.022","article-title":"Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents","volume":"115","author":"Rashid","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0240","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.bmcl.2013.09.047","article-title":"Synthesis and anti-parasitic activity of a novel quinolinone\u2013chalcone series","volume":"23","author":"Roussaki","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0245","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/AAC.38.6.1339","article-title":"Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani","volume":"38","author":"Chen","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0250","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/AAC.43.7.1776","article-title":"Improvement of in vitro and in vivo antileishmanial activities of 2\u2032,6\u2032-dihydroxy-4\u2032-methoxychalcone by entrapment in poly (D,L-lactide) nanoparticles","volume":"43","author":"Torres-Santos","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.actatropica.2006.02.001","article-title":"New administration model of trans-chalcone biodegradable polymers for the treatment of experimental leishmaniasis","volume":"98","author":"Pi\u00f1ero","year":"2006","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0260","first-page":"5529","article-title":"Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial design","volume":"10","author":"de Mattos","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0265","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0968-0896(98)00051-0","article-title":"Modifications of the \u03b1, \u03b2-double bond in chalcones only marginally affect the antiprotozoal activities","volume":"6","author":"Nielsen","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0270","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1021\/jm980410m","article-title":"Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure\u2013activity relationship analysis","volume":"41","author":"Nielsen","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0275","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bmc.2005.10.005","article-title":"Synthesis of chalcone analogues with increased antileishmanial activity","volume":"14","author":"Boeck","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0280","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.bmcl.2004.05.071","article-title":"A convenient and biogenetic type synthesis of few naturally occurring chromeno dihydrochalcones and their in vitro antileishmanial activity","volume":"14","author":"Narender","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0285","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1747-0285.2010.00959.x","article-title":"Chromene-based synthetic chalcones as potent antileishmanial agents: synthesis and biological activity","volume":"75","author":"Foroumadi","year":"2010","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exppara.2015.11.005","article-title":"Ultrastructural and morphological changes in Leishmania (Viannia) braziliensis treated with synthetic chalcones","volume":"160","author":"de Mello","year":"2016","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0295","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jac\/dkn546","article-title":"Altered sterol profile induced in Leishmania amazonensis by a natural dihydroxymethoxylated chalcone","volume":"63","author":"Torres-Santos","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0300","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.39.12.2742","article-title":"The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria","volume":"39","author":"Zhai","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0305","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/AAC.45.7.2023-2029.2001","article-title":"Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones","volume":"45","author":"Chen","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0310","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/eji.1830211216","article-title":"Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages","volume":"21","author":"Liew","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00436-008-1039-8","article-title":"In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis","volume":"103","author":"Campos","year":"2008","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2334-10-209","article-title":"Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production","volume":"10","author":"Souza","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0325","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.ijantimicag.2017.06.010_bib0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmgm.2013.12.010","article-title":"Antileishmanial phytochemical phenolics: molecular docking to potential protein targets","volume":"48","author":"Ogungbe","year":"2014","journal-title":"J Mol Graph Model"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T23:25:09Z","timestamp":1659137109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0924857917302200"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.06.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727766597.793580952","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chemotherapeutic potential of chalcones against leishmaniases: a review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}